ZANTE GREG bought VKTX
January 2, 2026 · Form 4 insider transaction
ZANTE GREG bought 91,000 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
91,000
Price
$0.00
Total value
N/A
InsiderZANTE GREG
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after91,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option will vest on each anniversary of the grant date.